The enrichment of exhausted CD8+ T cells and Tregs in dHpC likely reflects active tumor recognition by the immune system, followed by exhaustion and immune regulation, making these cancers potential candidates for immune checkpoint blockade. This evidence concerns the gene CD8A and cancer.